Delivery Order SPE2DB20D3111-SPE2DB24FA6GJ

Award Date 1/17/24
Potential Completion Date 1/18/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,387.86 firm fixed-price delivery order is for the supply of CARVEDILOL ER 40 MG CAPSULE 30S, a cardiovascular medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,308.35 firm fixed-price delivery order is for the provision of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award, valued at $3,139.83, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of CARVEDILOL ER 40 MG CAPSULE 30S, a cardiovascular medication, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,859.80 firm fixed-price delivery order is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,073.73 firm fixed-price delivery order is for the supply of CARVEDILOL ER 40 MG CAPSULE 30S, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,238.28 firm fixed-price delivery order is for the supply of CARVEDILOL ER 40 MG CAPSULE 30S, a cardiovascular medication. The contract has an ultimate completion date of March 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DB22D3010|SPE2DB24FP2XT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,901.20 firm fixed-price delivery order is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award, identified as SPE2DB22D3102|SPE2DB25FL0EK, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,438.90 firm fixed-price delivery order is for the supply of CARVEDILOL ER 40 MG CAPSULE 30S, a cardiovascular medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award is part of a larger...
This federal contract award, with ID SPE2DB20D3103|SPE2DB25FM1Q3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,940.20 firm fixed price delivery order is for the supply of CARVEDILOL ER 40 MG CAPSULE 30S, a cardiovascular medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,629.63 firm fixed-price delivery order is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB24FA6GJ
    Delivery Order

This federal contract award, with ID SPE2DB20D3111|SPE2DB24FA6GJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,070.36 firm-fixed-price delivery order is for the supply of CARVEDILOL ER 40 MG CAPSULE 30S, a cardiovascular medication.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/13/25, 9:50 AM